In the US, young and middle-aged women are being diagnosed with lung cancer at higher rates than men
Susan Wojcicki, the late CEO of YouTube, had a message for the world just weeks before she passed away in August: “Lung ...
News Medical on MSN12d
Scientists map cancer mutations in EGFR gene, revealing drug resistance paths
Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance ...
mskcc.org1d
How MSK Cares for a Young Woman Living With Stage 4 EGFR Lung Cancer
Learn how a young woman diagnosed with stage 4 non-small cell lung cancer had many treatment options because she came to MSK first.
Medindia2d
Colorectal Cancer Treatment: Role of Anti-EGFR Antibodies
Explore the challenges and advancements in anti-EGFR antibody treatment for metastatic colorectal cancer. Discover how ...
emjreviews.com10d
New Approach Offers Hope for Drug-Resistant Lung Cancer
A new study presents a customised treatment strategy using antisense oligonucleotides (ASOs) to target EGFR mutations in ...
Cure Today10d
FDA Receives Application for Dato-DXd Treatment in EGFR-Mutated NSCLC
For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated ...
The American Journal of Managed Care5d
Research Priorities Evolve With Amivantamab's Broader NSCLC Indications
In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...
AFP1d
Delta-Fly Pharma Inc.: Progress Update of the Phase III Clinical Trial of DFP-14323
We are excited to share our latest development status.
Metropolis Healthcare Unveils Key Findings From Molecular Genomics Study In Honour Of Lung Cancer Awareness Month
Mumbai, Maharashtra, India Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 ...
Alpha Biopharma Received NMPA Approval For Zorifertinib Tablets (Zorifer®), The World's First EGFR-TKI For Lung Cancer With Brain Metastases.
Zorifertinib is the first drug in the world to launch a registration clinical trial specifically for advanced NSCLC with CNS metastases and achieve remarkable results. It is also the only* EGFR ...